Scott grew up in Karratha, Western Australia and graduated from Curtin University with a BSc (Hons) before receiving his PhD from the University of Western Australia. He continued his postdoctoral training at the University of Michigan (Ann Arbor) and the City of Hope National Comprehensive Cancer Centre, Duarte, California, before returning to Perth where he joined NCARD in May 2008. Scott coordinates the pre‑clinical MexTAg research program. His research interests include investigating how an individuals’ genetic makeup contributes to mesothelioma development and how the body’s immune system interacts with the developing tumour. He supervises honours and PhD research students and lectures in tumour immunology.
Dr Scott Fisher
DR SCOTT FISHER
- Understanding how host genetics affect mesothelioma development after asbestos exposure. CIs: Lake RA., Fisher SA., Morahan G., Nowak AK., Lesterhuis WJ., Robinson B., Bueno R. Funded by: icare Dust Disease Care NSW (2018-2020); US Department of Defense (2018-2021); NHMRC (2019-2022).
- Assessing the carcinogenic potential of different asbestos and asbestiform fibres. CI Fisher SA., Lake., RA. Funded by NCARD (2018-2020)
- Understanding the impact of voluntary exercise as an adjunctive strategy to improve the efficacy and tolerability of anti-cancer treatment for mesothelioma. CI Fisher SA., Nowak AK., Peddle‑McIntyre CJ., Newton RU., Lake RA (2018). Funded by Slater and Gordon Health Research Fund; NCARD.
- Understanding the host-cancer immune response to better develop and use novel immunotherapies with the aim of improving treatment options for mesothelioma and other solid malignancies.
See Dr Scott Fisher’s UWA Profile for a full list of publications